Tjoung-Won Park-Simon
Ärztin
Hat mitgewirkt an:
-
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY
-
In vitro and in vivotherapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model
-
Prognose und Prädiktion bei nodalpositivem Mammakarzinom am Brustzentrum des Universitätsklinikums Halle an der Saale
-
Identification of novel breast cancer susceptibility genes and first steps towards mutation-specific cell culture models